Abstract
We analyzed the expression levels of fluoropyrimidine-metabolizing enzymes (thymidylate synthase [TS], dihydropyrimidine dehydrogenase [DPD], thymidine phosphorylase [TP] and orotate phosphoribosyltransferase [OPRT]) to identify potential biomarkers related to treatment outcomes in gastric cancer (GC) patients receiving adjuvant S-1 chemotherapy. In this study, 184 patients who received curative gastrectomy (D2 lymph node dissection) and adjuvant S-1 were included. Immunohistochemistry and quantitative reverse transcription polymerase chain reaction were performed to measure the protein and mRNA levels of TS, DPD, TP, and OPRT in tumor tissue. In univariate analysis, low intratumoral DPD protein expression was related to poorer 5-year disease-free survival (DFS; 78% vs. 88%; P = 0.068). Low intratumoral DPD mRNA expression (1st [lowest] quartile) was also related to poorer DFS (69% vs. 90%; P < 0.001) compared to high intratumoral DPD expression (2nd to 4th quartiles). In multivariate analyses, low intratumoral DPD protein or mRNA expression was related to worse DFS (P < 0.05), irrespective of other clinical variables. TS, TP, and OPRT expression levels were not related to treatment outcomes. Severe non-hematologic toxicities (...Continue Reading
References
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BeckG Milano
Jul 1, 1996·Anti-cancer Drugs·T ShirasakaM Fukushima
Apr 1, 2000·Japanese Journal of Cancer Research : Gann·Y IshikawaM Kitajima
Dec 24, 2002·Japanese Journal of Cancer Research : Gann·Hisataka FujiwaraMasakazu Fukushima
May 31, 2003·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hisashi UsukiHajime Maeta
May 31, 2003·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Masanori TerashimaMitsukazu Gotoh
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H FujiwaraT Shirasaka
Jun 1, 2006·International Journal of Cancer. Journal International Du Cancer·Wataru IchikawaRenzo Hirayama
Jul 1, 2006·Cancer Investigation·Hiroyuki FukudaMasaru Miyazaki
Feb 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-C KwonH-J Kim
Mar 1, 2008·Cancer Chemotherapy and Pharmacology·Hidekazu KuramochiMasakazu Yamamoto
Aug 12, 2008·Anti-cancer Drugs·Wasaburo KoizumiUNKNOWN Clinical Study Group of Capecitabine
Apr 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yeul Hong Kim
Jun 10, 2010·Medical Oncology·In Sil ChoiJong Seok Lee
May 4, 2011·Journal of Surgical Oncology·Naru KondoTaijiro Sueda
May 17, 2011·Anti-cancer Drugs·Hei-Cheul JeungHyun Cheol Chung
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitsuru SasakoYasuo Ohashi
Jan 10, 2012·Lancet·Yung-Jue BangUNKNOWN CLASSIC trial investigators
May 17, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KimK-W Lee
Aug 7, 2012·Cancer Chemotherapy and Pharmacology·Jae Ho JeongYoon-Koo Kang
Sep 25, 2012·BMC Cancer·Hiroki IdeMototsugu Oya
Oct 16, 2012·Cancer Chemotherapy and Pharmacology·Yuehong CuiTianshu Liu
Oct 17, 2012·Cancer Science·Su-Jung KimKeun-Wook Lee
Oct 20, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erin M BertinoMiguel A Villalona-Calero
Jan 13, 2015·Journal of Gastric Cancer·Paul Vincent CoMelchor Demetria
Mar 21, 2015·PloS One·Ji-Yeon KimKeun-Wook Lee
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KimK-W Lee
Citations
Mar 21, 2015·PloS One·Ji-Yeon KimKeun-Wook Lee
Mar 4, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Namju KimKeun-Wook Lee
May 18, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Eiji HishinumaMasahiro Hiratsuka
Mar 26, 2016·The International Journal of Biological Markers·Dan WangXiuwen Wang
Jul 28, 2020·Journal of Clinical Medicine·Eiji HishinumaMasahiro Hiratsuka
Mar 4, 2017·Disease Markers·Cong ZhangZhenning Wang